Evidence map›Paper›PMID 40357654›Full record

Trial reportJournal of the American Heart Association2025

Effect of Remote Ischemic Conditioning and Red Blood Cells Biomarkers on Outcomes in Patients With Acute Stroke.

Rolf Ankerlund Blauenfeldt, Jennifer L Waller, Kim Ryun Drasbek, Jesper Nørgaard Bech, Anne-Mette Hvas, Julie Brogaard Larsen, Morten Nørgaard Andersen, Marlene Christina Nielsen, Maria Kjølhede, Mathilde Kjeldsen and 5 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Cytoprotection Concepts for Ischemic Stroke in the Recanalization Era.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rolf Ankerlund BlauenfeldtDepartment of Neurology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0002-4846-9516
Jennifer L WallerDepartment of Family and Community Medicine, Medical College of Georgia Augusta University Augusta GA USA.ORCID 0000-0003-4066-4541
Kim Ryun DrasbekCenter for Functionally Integrative Neuroscience Aarhus University Aarhus Denmark.ORCID 0000-0003-2701-2741
Jesper Nørgaard BechDepartment of Clinical Medicine Aarhus University Aarhus Denmark.ORCID 0000-0002-0605-1277
Anne-Mette HvasCenter for Thrombosis and Hemostasis, Department of Clinical Biochemistry Aarhus University Hospital Aarhus Denmark.ORCID 0000-0002-7136-7534
Julie Brogaard LarsenDepartment of Clinical Medicine Aarhus University Aarhus Denmark.
Morten Nørgaard AndersenDepartment of Clinical Medicine Aarhus University Aarhus Denmark.ORCID 0000-0003-0820-7789
Marlene Christina NielsenCenter for Thrombosis and Hemostasis, Department of Clinical Biochemistry Aarhus University Hospital Aarhus Denmark.ORCID 0000-0003-2008-4224
Maria KjølhedeDepartment of Neurology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0003-1544-6104
Mathilde KjeldsenUniversity Clinic in Nephrology and Hypertension Gødstrup Regional Hospital Herning Denmark.
Martin F GudeDepartment of Clinical Medicine Aarhus University Aarhus Denmark.ORCID 0000-0003-2888-1842
Mohammad Badruzzaman KhanDepartment of Neurology, Medical College of Georgia Augusta University Augusta GA USA.ORCID 0000-0001-8231-1256
Babak BabanDepartment of Neurology, Medical College of Georgia Augusta University Augusta GA USA.ORCID 0000-0002-3144-2288
Grethe AndersenDepartment of Neurology Aarhus University Hospital Aarhus Denmark.ORCID 0000-0001-6807-2500
David C HessDepartment of Neurology, Medical College of Georgia Augusta University Augusta GA USA.ORCID 0000-0002-8345-9153

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRemote ischemic conditioning (RIC) is a simple and low-cost intervention that is thought to increase collateral blood flow through the vasodilatory effects of nitric oxide (NO) produced by the endothelium and red blood cells (RBCs). The aim of this study was to investigate whether RBC form and function are associated with short- and long-term outcomes in patients with acute ischemic stroke, and whether RIC treatment modified this effect. METHODS AND

resultsThis is a predefined substudy to the RESIST (Remote Ischemic Conditioning in Patients with Acute Stroke Trial) randomized clinical trial conducted in Denmark. RIC was started in the ambulance and continued at the hospital for 7 days. RBC deformability and erythrocyte aggregation rate were assessed using ektacytometry, NO using flowcytometry, and nitrite content using ozone chemiluminescence. Logistic regression and mixed effect models were used. Out of 1500 prehospital randomized patients, and between July 28, 2020 and November 11, 2023, 486 patients had blood samples taken. Of these 249 (51%) had acute ischemic stroke and were included in this study. In the acute phase, higher levels of RBC deformability, aggregation, and RBC NO content were associated with worse clinical outcome if patients were treated with RIC compared with sham. Similar results were found at 24 hours, except for a potential effect on early neurological improvement in RIC-treated patients with an increased deformability level at 24 hours.

conclusionsRIC may have time-dependent and biomarker-specific effects on stroke outcomes, and detrimental interactions between increasing biomarker levels and RIC were observed. This may explain previous failures to translate RIC into an effective neuroprotective therapy in the hyperacute phase.

Indexed as

ErythrocytesIschemic PreconditioningIschemic StrokeStrokeAgedBiomarkersDenmarkErythrocyte AggregationErythrocyte DeformabilityFemaleHumansMaleMiddle AgedNitric OxideTreatment OutcomeBiomarkersNitric Oxidedeformabilityischemic strokenitric oxidenitriteoutcomered blood cellremote ischemic conditioning

Identifiers

PMID40357654
PMCPMC12184582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.